🩺 Expert Opinion Update by Dr. Chetan R. Kalal
Maharashtra’s First DM Hepatologist | India’s Leading Liver & Transplant Specialist | Virtual Consults Worldwide
⚕️ Hepatology in 2025 – Where We Stand
Liver disease is no longer a hidden epidemic. In India, fatty liver (MASLD/NASH), viral hepatitis, and alcohol-related liver disease are now the leading causes of cirrhosis.
Key update: Non-invasive diagnostics (FibroScan, MRI-PDFF, advanced biomarkers) allow early detection — before cirrhosis develops.
Dr. Kalal’s perspective:
"The future of hepatology is shifting from late diagnosis to early detection. Every patient with obesity, diabetes, or alcohol use must treat liver check-ups as seriously as blood pressure or sugar testing."
🏥 IPD & Liver Transplant Expertise in Mumbai
As one of India’s foremost liver specialists, Dr. Kalal provides end-to-end inpatient (IPD) and transplant services across leading hospitals in Mumbai.
In-Patient Services (IPD):
Acute liver failure management in ICU
Cirrhosis with ascites, GI bleed, or encephalopathy
Advanced liver diagnostics, biopsy, and critical care
Bridging therapies: therapeutic plasma exchange, chelation, nutrition
Pre- and post-transplant stabilization
Dr. Kalal’s view:
"A liver transplant is never just a surgery. It is a journey that starts with IPD stabilization, continues through transplant, and lasts a lifetime with follow-up care."
Mumbai Locations:
Patients can access Dr. Kalal’s expertise across Mumbai’s leading neighborhoods:
Andheri | Bandra | Worli | Navi Mumbai
Lokhandwala | Khar | Vile Parle
Also accessible from Juhu, Lower Parel, Dadar, Pali Hill
⚖️ Obesity & Liver – The New Epidemic
Obesity has silently become the biggest risk factor for fatty liver, diabetes, and even liver cancer. In Mumbai and across India, 1 in 3 adults is overweight — and the liver is the hidden casualty.
Latest Updates:
GLP-1 agonists (Semaglutide, Tirzepatide): Proven to reduce weight and liver fat.
Resmetirom (Rezdiffra): First FDA-approved drug for NASH, now guiding liver health protocols worldwide.
Lifestyle therapy: Even a 7–10% weight loss can reverse fatty liver in most patients.
Dr. Kalal emphasizes:
"Obesity is not just a cosmetic issue — it is liver disease in disguise. For many patients, losing 7–10% weight is equivalent to reversing years of liver damage. With modern therapies and structured clinics, we finally have medical tools to fight back."
🌍 Global Virtual Consults
Alongside Mumbai-based care, Dr. Kalal provides virtual consultations to patients in:
UAE, Middle East, Africa – Cirrhosis, hepatitis B/C, fatty liver
USA, Canada, Europe – NASH, transplant second opinions
Australia & New Zealand – Advanced hepatology, bridging therapies
"Whether you are in Andheri or Australia, my goal is the same — evidence-based, compassionate liver care accessible to all."
❓ FAQs
Q: Where can I consult Dr. Kalal in Mumbai?
Dr. Kalal sees patients in Andheri, Bandra, Worli, Navi Mumbai, Lokhandwala, Khar, Vile Parle, and nearby hubs like Juhu, Lower Parel, Pali Hill, Dadar.
Q: Does Dr. Kalal offer IPD services?
Yes. Patients can be admitted under his direct IPD care for cirrhosis, acute liver failure, or transplant evaluation.
Q: What are the latest treatments for fatty liver?
Weight loss therapies, GLP-1/GIP agonists (e.g., Tirzepatide), and new drugs like Resmetirom are now available.
Q: Is liver transplant in India safe?
Yes. Mumbai centers under expert teams achieve global-level outcomes at far lower costs.
Q: Can I get a second opinion online?
Yes. Dr. Kalal offers structured virtual consultations and second opinions for patients in India and worldwide.
📢 Conclusion
Liver care is entering a new era — with early diagnostics, advanced IPD services, innovative obesity drugs, and world-class transplants in Mumbai.
👉 From Andheri to Navi Mumbai, and from India to global virtual clinics, Dr. Chetan Kalal stands as a trusted leader in hepatology and liver transplant care.
